115 related articles for article (PubMed ID: 7478833)
1. Controlled trial of dexamethasone in neonatal chronic lung disease: a 3-year follow-up.
Jones R; Wincott E; Elbourne D; Grant A
Pediatrics; 1995 Nov; 96(5 Pt 1):897-906. PubMed ID: 7478833
[TBL] [Abstract][Full Text] [Related]
2. Randomized, controlled trial of dexamethasone in neonatal chronic lung disease: 13- to 17-year follow-up study: I. Neurologic, psychological, and educational outcomes.
Jones RA;
Pediatrics; 2005 Aug; 116(2):370-8. PubMed ID: 16061591
[TBL] [Abstract][Full Text] [Related]
3. Randomized, controlled trial of dexamethasone in neonatal chronic lung disease: 13- to 17-year follow-up study: II. Respiratory status, growth, and blood pressure.
Jones RA;
Pediatrics; 2005 Aug; 116(2):379-84. PubMed ID: 16061592
[TBL] [Abstract][Full Text] [Related]
4. Dexamethasone therapy in neonatal chronic lung disease: an international placebo-controlled trial. Collaborative Dexamethasone Trial Group.
Pediatrics; 1991 Sep; 88(3):421-7. PubMed ID: 1881718
[TBL] [Abstract][Full Text] [Related]
5. Controlled trial of dexamethasone in neonatal chronic lung disease: an 8-year follow-up of cardiopulmonary function and growth.
Mieskonen S; Eronen M; Malmberg LP; Turpeinen M; Kari MA; Hallman M
Acta Paediatr; 2003 Aug; 92(8):896-904. PubMed ID: 12948063
[TBL] [Abstract][Full Text] [Related]
6. Follow-up at 15 years of preterm infants from a controlled trial of moderately early dexamethasone for the prevention of chronic lung disease.
Gross SJ; Anbar RD; Mettelman BB
Pediatrics; 2005 Mar; 115(3):681-7. PubMed ID: 15741372
[TBL] [Abstract][Full Text] [Related]
7. Outcome at 2 years of age of infants from the DART study: a multicenter, international, randomized, controlled trial of low-dose dexamethasone.
Doyle LW; Davis PG; Morley CJ; McPhee A; Carlin JB;
Pediatrics; 2007 Apr; 119(4):716-21. PubMed ID: 17403842
[TBL] [Abstract][Full Text] [Related]
8. A multicenter trial of two dexamethasone regimens in ventilator-dependent premature infants.
Papile LA; Tyson JE; Stoll BJ; Wright LL; Donovan EF; Bauer CR; Krause-Steinrauf H; Verter J; Korones SB; Lemons JA; Fanaroff AA; Stevenson DK
N Engl J Med; 1998 Apr; 338(16):1112-8. PubMed ID: 9545359
[TBL] [Abstract][Full Text] [Related]
9. Decreased use of postnatal corticosteroids in extremely preterm infants without increasing chronic lung disease.
Seth R; Gray PH; Tudehope DI
Neonatology; 2009; 95(2):172-8. PubMed ID: 18776732
[TBL] [Abstract][Full Text] [Related]
10. Follow-up of a randomized, placebo-controlled trial of dexamethasone to decrease the duration of ventilator dependency in very low birth weight infants: neurodevelopmental outcomes at 4 to 11 years of age.
O'Shea TM; Washburn LK; Nixon PA; Goldstein DJ
Pediatrics; 2007 Sep; 120(3):594-602. PubMed ID: 17766533
[TBL] [Abstract][Full Text] [Related]
11. Outcomes at school age after postnatal dexamethasone therapy for lung disease of prematurity.
Yeh TF; Lin YJ; Lin HC; Huang CC; Hsieh WS; Lin CH; Tsai CH
N Engl J Med; 2004 Mar; 350(13):1304-13. PubMed ID: 15044641
[TBL] [Abstract][Full Text] [Related]
12. Early treatment of premature infants with steroids: neurological sequelae.
Prescrire Int; 2007 Jun; 16(89):108-9. PubMed ID: 17582929
[TBL] [Abstract][Full Text] [Related]
13. Neonatal dexamethasone treatment for chronic lung disease of prematurity alters the hypothalamus-pituitary-adrenal axis and immune system activity at school age.
Karemaker R; Kavelaars A; ter Wolbeek M; Tersteeg-Kamperman M; Baerts W; Veen S; Samsom JF; Visser GH; van Bel F; Heijnen CJ
Pediatrics; 2008 Apr; 121(4):e870-8. PubMed ID: 18381516
[TBL] [Abstract][Full Text] [Related]
14. Neurodevelopmental outcome and growth at 18 to 22 months' corrected age in extremely low birth weight infants treated with early erythropoietin and iron.
Ohls RK; Ehrenkranz RA; Das A; Dusick AM; Yolton K; Romano E; Delaney-Black V; Papile LA; Simon NP; Steichen JJ; Lee KG;
Pediatrics; 2004 Nov; 114(5):1287-91. PubMed ID: 15520109
[TBL] [Abstract][Full Text] [Related]
15. Follow-up of a randomized, placebo-controlled trial of postnatal dexamethasone: blood pressure and anthropometric measurements at school age.
Washburn LK; Nixon PA; O'Shea TM
Pediatrics; 2006 Oct; 118(4):1592-9. PubMed ID: 17015551
[TBL] [Abstract][Full Text] [Related]
16. The efficacy of nebulized budesonide in dexamethasone-treated outpatients with croup.
Klassen TP; Watters LK; Feldman ME; Sutcliffe T; Rowe PC
Pediatrics; 1996 Apr; 97(4):463-6. PubMed ID: 8632929
[TBL] [Abstract][Full Text] [Related]
17. Randomized controlled trial of three different doses of aerosol beclomethasone versus systemic dexamethasone to promote extubation in ventilated premature infants.
Rozycki HJ; Byron PR; Elliott GR; Carroll T; Gutcher GR
Pediatr Pulmonol; 2003 May; 35(5):375-83. PubMed ID: 12687595
[TBL] [Abstract][Full Text] [Related]
18. Dexamethasone inner ear perfusion by intratympanic injection in unilateral Ménière's disease: a two-year prospective, placebo-controlled, double-blind, randomized trial.
Garduño-Anaya MA; Couthino De Toledo H; Hinojosa-González R; Pane-Pianese C; Ríos-Castañeda LC
Otolaryngol Head Neck Surg; 2005 Aug; 133(2):285-94. PubMed ID: 16087029
[TBL] [Abstract][Full Text] [Related]
19. [Extreme prematurity: comparison of outcome at 5 years depending on gestational age below or above 26 weeks].
Autret F; Kieffer F; Tasseau A; Rigourd V; Valleur D; Voyer M; Magny JF
Arch Pediatr; 2009 Jul; 16(7):976-83. PubMed ID: 19403280
[TBL] [Abstract][Full Text] [Related]
20. Two-year infant neurodevelopmental outcome after single or multiple antenatal courses of corticosteroids to prevent complications of prematurity.
Spinillo A; Viazzo F; Colleoni R; Chiara A; Maria Cerbo R; Fazzi E
Am J Obstet Gynecol; 2004 Jul; 191(1):217-24. PubMed ID: 15295369
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
